Minute Insight: Abbott Touts 14-Day FreeStyle Libre 3 Data

08 Jun 2022

Shortly after the FDA approved Abbott's FreeStyle Libre 3 continuous glucose monitor system, the company announced new clinical data showing that it is the most accurate 14-day CGM system available.

Minute Insight — • Source: Informa/Alamy

Minute Insight: Abbott Touts 14-Day FreeStyle Libre 3 Data

More from Minute Insights

More from Medtech Insight